{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000055","form_type":"8-K","ticker":"HSCS","cik":"0001468492","company_name":"HeartSciences Inc.","filed_at":"2023-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.120792+00:00","generated_at":"2026-06-20T20:50:00.846847+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Heart Test Laboratories board changes: Kanouff resigns, Wells appointed","bullets":["Director Patrick Kanouff voluntarily resigned from board and all committees effective Dec 27, 2022.","David R. Wells appointed to board effective Dec 28, 2022; serves on Audit, Compensation, and Nominating committees.","Wells is independent; background includes CFO at ENDRA Life Sciences and GHS Investments, founder of Atlas Bookkeeping."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000055","json":"https://secwatch.observer/filing/0000950170-23-000055.json","markdown":"https://secwatch.observer/filing/0000950170-23-000055.md","text":"https://secwatch.observer/filing/0000950170-23-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/0000950170-23-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/hscs-20221227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T20:50:00.846847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a97beae89a","claim":"Patrick Kanouff resigned as Director at HeartSciences Inc..","evidence_excerpt":"Effective December 27, 2022, Patrick Kanouff voluntarily resigned from the Board of Directors (the “Board”) of Heart Test Laboratories, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/0000950170-23-000055-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"faaffa6149","claim":"David R. Wells was appointed as Director at HeartSciences Inc..","evidence_excerpt":"Effective December 28, 2022, the Board appointed David R. Wells to the Board as a director to fill the vacancy created by Mr. Kanouff’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/0000950170-23-000055-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}